About this trial
This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.
Eligibility criteria
Qualifiers
Level III NICU
Affiliated with Kaiser Permanente Northern California (KPNC) or Children's Hospital of Philadelphia Newborn Care Network (CNBCN)
Recruited by study team
Disqualifiers
Site not recruited for the study
Trial design
Treatments tested in this trial
- External Facilitation
Treatment groups
Sponsors and collaborators
Children's Hospital of Philadelphia
Lead sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator